Search clinical trials for: NN9924 (oral)

Total 8184 results

Novo Nordisk A/S

Completed

A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects

Healthy | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Biogen

Terminated

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants (RESPOND-EXT)

Rheumatoid Arthritis

Argentina, Brazil, Hungary, Mexico, Poland, Romania, Russian Federation, United Kingdom
Novo Nordisk A/S

Completed

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

Obesity | Overweight | Healthy Volunteers

United States
Biogen

Completed

Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, United States
Eunice Kennedy Shriver National Institute of Child...

Terminated

Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones

Amenorrhea | Aplastic Anemia | Menorrhagia

United States
Biogen

Terminated

BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Bayer

Completed

To Evaluate Clinical Outcome and Injection Compliance of Scilin (SEAS)

Diabetes Mellitus, Type 2

China
Biogen

Terminated

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

Rheumatoid Arthritis

United States, Belgium, Canada, United Kingdom
Burnasyan Federal Medical Biophysical Center

Completed

Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers

Angina Pectoris | Stroke, Not Specified as Hemorrhage or Infarction

Russian Federation
Université de Montréal
St. Justine's Hospital

Terminated

Comparison of Two Oral Myofunctional Reeducation Methods for Children With Obstructive Sleep Apnea (PERSIST-B)

Obstructive Sleep Apnea

Canada
Estetra
ICON Clinical Research

Completed

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort)

Vasomotor Symptoms | Menopausal Symptoms

United States, Canada
Pulmagen Therapeutics

Completed

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

Atopic Asthma

United Kingdom
Mansoura University

Completed

Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO)

Small Bowel Obstruction

Egypt
Turning Point Therapeutics, Inc.

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Lymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS Tumors

United States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
German Institute of Human Nutrition
Ludwig-Maximilians - University of Munich

Completed

Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1 (ILIAS-1)

Diabetes | Pre-diabetes

Germany
Applied Molecular Transport

Active, not recruiting

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Ulcerative Colitis

United States, Hungary, Ukraine, Germany, United Kingdom, Belarus, Bulgaria, Canada, France, Georgia, Moldova, Republic of, Poland, Russian Federation, Switzerland
Brigham and Women's Hospital

Completed

Characterizing Upper Airway Collapse to Guide Patient Selection for Oral Appliance Therapy for Obstructive Sleep Apnea

Sleep Apnea, Obstructive

United States
Wockhardt

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349

Pharmacokinetics
Mayo Clinic
National Center for Advancing Translational Sciences (NCATS)

Completed

MPO Inhibitor A_Zeneca for HFpEF

Heart Failure

United States
Ain Shams University

Completed

Early Versus Traditional Oral Hydration After Cesarean Section

Gastrointestinal Motility and Defecation Conditions

Egypt
Yonsei University

Completed

Gender and Proper Size of Oropharyngeal Airway: Pilot Study

Adult Patients Undergoing Surgery That Requires General Anesthesia

Korea, Republic of
Johns Hopkins University
Canopy Growth Corporation

Recruiting

Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants

Behavioral Pharmacology of Cannabis

United States
Vanda Pharmaceuticals

Completed

Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers

Healthy

United States
Harmony Biosciences, LLC

Active, not recruiting

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

Myotonic Dystrophy 1 | Excessive Daytime Sleepiness

United States, Canada
Syntrix Biosystems, Inc.
National Institute on Drug Abuse (NIDA); DF/Net Research

Completed

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Diabetic Neuropathies | Neuropathic Pain | Pain, Chronic

United States
Segi University

Completed

Oral Stereognosis in Completely Edentulous Patient With Maxillary Tori

Torus Palatinus and Torus Mandibularis

Malaysia
Aelis Farma
National Institute on Drug Abuse (NIDA)

Completed

Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Healthy Volunteers

United States
Lithuanian University of Health Sciences
Klaipėda University; Vita Longa Clinic

Completed

Faringomoss Effectiveness in Inhibiting Acute Throat Pain and Discomfort

Mouth Diseases | Throat Pain | Spraying Behavior | Throat Diseases

Lithuania
St. Joseph's Hospital and Medical Center, Phoenix
Lund University

Completed

Effects of Oral Care in the Neuroscience ICU

Oral Hygiene | Ventilator Associated Pneumonia

United States
EicOsis Human Health Inc.

Recruiting

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects

Healthy Subjects

New Zealand
Loma Linda University

Completed

Oral Sucrose Versus Glucose for Procedural Pain in Premature Neonates

Neonatal Procedural Pain

United States
Brigham and Women's Hospital

Completed

DAW1033D in Obstructive Sleep Apnea (OSAstimD)

Obstructive Sleep Apnea (OSA)

United States
Ain Shams Maternity Hospital

Completed

Early Versus Late Hydration After Cesarean Section (CS)

Gastrointestinal Motility and Defaecation Conditions

Egypt
The University of Hong Kong

Unknown

Treatment of Sleep Apnea With Oral Appliances

Obstructive Sleep Apnea

Hong Kong
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States
Paolone Gaetano

Not yet recruiting

Study on the Chromatic Perception of Digital Systems in Aesthetic Field

Color Detection of Upper Central Incisors

Italy
University of Oxford
Novo Nordisk A/S

Recruiting

A Study of Cardiovascular Events iN Diabetes Plus (ASCEND PLUS)

Diabetes Mellitus, Type 2

United Kingdom
Fulcrum Therapeutics

Terminated

Losmapimod Safety and Efficacy in COVID-19 (LOSVID)

COVID-19

United States, Mexico, Brazil, Peru
Universidad de Almeria

Enrolling by invitation

Physiotherapy to Improve Feeding Skills in Preterm Infants

Premature Birth | Neurodevelopmental Disorders | Motor Disorders | Parenteral Nutrition | Sucking Behavior

Spain
EicOsis Human Health Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy Subjects

Healthy Adults

United States
Harmony Biosciences, LLC

Active, not recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

Prader-Willi Syndrome

United States
Brigham and Women's Hospital

Enrolling by invitation

DAW2020 on OSA Endotypic Traits (SedOSA)

Obstructive Sleep Apnea (OSA)

United States

Search clinical trials for: NN9924 (oral)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations